Annual SGA
$11.77 M
-$2.10 M-15.15%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual SGA is $11.77 million, with the most recent change of -$2.10 million (-15.15%) on December 31, 2023.
- During the last 3 years, APVO annual SGA has fallen by -$2.18 million (-15.63%).
- APVO annual SGA is now -72.65% below its all-time high of $43.04 million, reached on December 31, 2015.
Performance
APVO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.11 M
-$271.00 K-11.38%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly SGA is $2.11 million, with the most recent change of -$271.00 thousand (-11.38%) on September 30, 2024.
- Over the past year, APVO quarterly SGA has dropped by -$683.00 thousand (-24.45%).
- APVO quarterly SGA is now -85.08% below its all-time high of $14.14 million, reached on December 31, 2015.
Performance
APVO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$931.16 M
-$23.72 M-2.61%
September 30, 2024
Summary
- As of February 8, 2025, APVO TTM SGA is -$931.16 million, with the most recent change of -$23.72 million (-2.61%) on September 30, 2024.
- Over the past year, APVO TTM SGA has dropped by -$942.93 million (-8010.60%).
- APVO TTM SGA is now -301.38% below its all-time high of -$231.99 million.
Performance
APVO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
APVO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.2% | -24.4% | -8010.6% |
| 3 y3 years | -15.6% | -24.4% | -8010.6% |
| 5 y5 years | -58.2% | -40.2% | -5848.6% |
APVO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | at low | -45.3% | at low | -15.8% | at low |
| 5 y | 5-year | -27.3% | at low | -50.7% | at low | -50.3% | at low |
| alltime | all time | -72.7% | at low | -85.1% | at low | -301.4% | at low |
Aptevo Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.11 M(-11.4%) | $10.52 M(-5.1%) |
| Jun 2024 | - | $2.38 M(-26.3%) | $11.08 M(-2.9%) |
| Mar 2024 | - | $3.23 M(+15.7%) | $11.41 M(-3.0%) |
| Dec 2023 | $11.77 M(-15.2%) | $2.79 M(+4.5%) | $11.77 M(-1.8%) |
| Sep 2023 | - | $2.67 M(-1.5%) | $11.99 M(-5.0%) |
| Jun 2023 | - | $2.72 M(-24.3%) | $12.62 M(-7.2%) |
| Mar 2023 | - | $3.59 M(+19.2%) | $13.60 M(-2.0%) |
| Dec 2022 | $13.87 M(-5.6%) | $3.01 M(-9.0%) | $13.87 M(-1.1%) |
| Sep 2022 | - | $3.31 M(-10.5%) | $14.03 M(-1.2%) |
| Jun 2022 | - | $3.70 M(-4.2%) | $14.20 M(-2.8%) |
| Mar 2022 | - | $3.86 M(+22.0%) | $14.61 M(-0.6%) |
| Dec 2021 | $14.70 M(+5.4%) | $3.16 M(-9.1%) | $14.70 M(-7.1%) |
| Sep 2021 | - | $3.48 M(-15.4%) | $15.82 M(+1.7%) |
| Jun 2021 | - | $4.11 M(+4.1%) | $15.55 M(+8.9%) |
| Mar 2021 | - | $3.95 M(-7.8%) | $14.28 M(+2.4%) |
| Dec 2020 | $13.95 M(-13.9%) | $4.28 M(+33.1%) | $13.95 M(+5.7%) |
| Sep 2020 | - | $3.21 M(+13.2%) | $13.20 M(-4.7%) |
| Jun 2020 | - | $2.84 M(-21.5%) | $13.85 M(-9.4%) |
| Mar 2020 | - | $3.62 M(+2.5%) | $15.29 M(-5.6%) |
| Dec 2019 | $16.20 M | $3.53 M(-8.7%) | $16.20 M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.86 M(-9.7%) | $19.25 M(-13.8%) |
| Jun 2019 | - | $4.28 M(-5.5%) | $22.32 M(-10.9%) |
| Mar 2019 | - | $4.53 M(-31.2%) | $25.07 M(-10.9%) |
| Dec 2018 | $28.13 M(-18.6%) | $6.58 M(-5.2%) | $28.13 M(-6.6%) |
| Sep 2018 | - | $6.94 M(-1.2%) | $30.11 M(-1.7%) |
| Jun 2018 | - | $7.02 M(-7.5%) | $30.64 M(-4.4%) |
| Mar 2018 | - | $7.59 M(-11.3%) | $32.04 M(-7.3%) |
| Dec 2017 | $34.58 M(-4.4%) | $8.56 M(+14.5%) | $34.58 M(+1.0%) |
| Sep 2017 | - | $7.47 M(-11.2%) | $34.23 M(-9.7%) |
| Jun 2017 | - | $8.42 M(-16.9%) | $37.90 M(-1.1%) |
| Mar 2017 | - | $10.13 M(+23.4%) | $38.33 M(+1.9%) |
| Dec 2016 | $36.16 M(-16.0%) | $8.21 M(-26.3%) | $37.63 M(-13.6%) |
| Sep 2016 | - | $11.14 M(+25.8%) | $43.56 M(+6.4%) |
| Jun 2016 | - | $8.86 M(-6.0%) | $40.93 M(-3.8%) |
| Mar 2016 | - | $9.42 M(-33.4%) | $42.53 M(-1.2%) |
| Dec 2015 | $43.04 M(+25.6%) | $14.14 M(+66.1%) | $43.04 M(+48.9%) |
| Sep 2015 | - | $8.51 M(-18.6%) | $28.90 M(+41.8%) |
| Jun 2015 | - | $10.46 M(+5.3%) | $20.39 M(+105.3%) |
| Mar 2015 | - | $9.93 M | $9.93 M |
| Dec 2014 | $34.28 M(+121.9%) | - | - |
| Dec 2013 | $15.45 M | - | - |
FAQ
- What is Aptevo Therapeutics annual SGA?
- What is the all time high annual SGA for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual SGA year-on-year change?
- What is Aptevo Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly SGA year-on-year change?
- What is Aptevo Therapeutics TTM SGA?
- What is the all time high TTM SGA for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM SGA year-on-year change?
What is Aptevo Therapeutics annual SGA?
The current annual SGA of APVO is $11.77 M
What is the all time high annual SGA for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual SGA is $43.04 M
What is Aptevo Therapeutics annual SGA year-on-year change?
Over the past year, APVO annual SGA has changed by -$2.10 M (-15.15%)
What is Aptevo Therapeutics quarterly SGA?
The current quarterly SGA of APVO is $2.11 M
What is the all time high quarterly SGA for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly SGA is $14.14 M
What is Aptevo Therapeutics quarterly SGA year-on-year change?
Over the past year, APVO quarterly SGA has changed by -$683.00 K (-24.45%)
What is Aptevo Therapeutics TTM SGA?
The current TTM SGA of APVO is -$931.16 M
What is the all time high TTM SGA for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM SGA is -$231.99 M
What is Aptevo Therapeutics TTM SGA year-on-year change?
Over the past year, APVO TTM SGA has changed by -$942.93 M (-8010.60%)